Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.12.25Milestone wins first-ever FDA approval with green light for heart arrhythmia nasal spray
12.12.25FDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence
12.12.25GSK's long-acting asthma med scores in suite of CHMP drug endorsements
12.12.25New CDC report backs COVID vaccine effectiveness in children as vaccine safety probe heats up at FDA
12.12.25NanoVibronix feeds into new focus on ENvue enteral system with rebrand
12.12.25GSK gains FDA expansion for Blujepa to treat gonorrhea
12.12.25Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod
12.12.25Fierce Pharma Asia-Pfizer, Zealand metabolic disease deals; China's 1st private insurance formulary
11.12.25European legislators reach agreement on sweeping overhaul to pharma policies
11.12.25Geron to lay off third of workforce in bid to slash operating costs
11.12.25Abbott teams up with Serena Williams again in Lingo CGM push
11.12.25Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
11.12.25Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg
10.12.25FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says
10.12.25CDMO Adare plots 137 layoffs in Philly shortly after transplanting headquarters from N.J.
10.12.25AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study
10.12.25FDA awards 1st national priority nod to USAntibiotics' Augmentin XR
10.12.25In win for pharma, UK cuts medicine rebate rate following US intervention
10.12.25FDA finalizes guidance on promotional materials for biologics and biosimilars
10.12.25Italian nonprofit lands FDA approval for first gene therapy to treat rare genetic disease
10.12.25After deal spree, Supreme Group unites agencies to form new PR and communications group
09.12.25CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development
09.12.25Genentech uncovers 'Hidden GeMS' in latest iteration of multiple sclerosis visibility drive
09.12.25Roll Tide: Lilly selects Alabama site as location for $6B API facility
09.12.25Biocon buys out Viatris and others from biosimilar subsidiary